JD

Jun Deng

Venture Capital, Healthcare & Life Sciences

Palo Alto, California

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $50,000.00

  • Max Investment:

    $1,000,000.00

  • Target Investment:

    $500,000.00

Skills

Cell Biology
Genetics
Biotechnology
Lifesciences
Investment
Investments
Operations Management
Organizational Leadership
Start-ups
Research

Education

Lists including Jun

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

InformAI

Seed

Total Funding: $2M

Work Experience

Joyance Partners

2018

  • Partner

    2018

    Investing in companies that, through science and tech, cultivate joy to improve the way we live.

C the Signs

2023

  • Board Observer

    2023

Volumetric

2019

  • Investor

    2019

    Acquired by 3D System (NYSE:DDD) https://www.businesswire.com/news/home/20211027006115/en/Volumetric-to-Be-Acquired-by-3D-Systems-to-Advance-Tissue-and-Organ-Manufacturing

Osmosis - Knowledge Diffusion

2018

  • Investor

    2018

    Acquired by Reed Elsevier (NYSE: RELX) https://technical.ly/2021/12/03/osmosis-acquired-elsivier/

Loop Genomics

2016

  • Investor

    2016

    Acquired by Element Biosciences

Silicon Valley Bank

2022

  • Seed/A advisor

    2022

UCSF Health Hub

2022

  • Judge

    2022

Endless Frontier Labs

2021

  • Mentor

    2021

    https://endlessfrontierlabs.com/mentors/

HealthTech Capital

2018

  • Investor

    2018

    Created a strategic partnership between Joyance and HealthTech Capital, optimizing investment opportunities Funded and mentored startups that decrease healthcare costs or empower the patients by leveraging data insights

Nymbl Science

2019

  • Board Observer

    2019

    Nymbl is a digital health company that provides the first scalable fall prevention to improve population health in senior adults